Mylan Is Offering An EpiPen Savings Card, But A Lot Of People Will Still Get Screwed

By: via Benzinga
It’s been a rough week for Mylan NV (NASDAQ: MYL). To stem the tide of criticism over price hikes of its EpiPen, CEO ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.